GLAXO.BO
GlaxoSmithKline Pharmaceuticals Limited$2,166.30
Jun 05, 2026
Market cap
$366.61B
52w range
—
P / E
—
EPS · FY 2026
$61.15
Volume
—
Revenue · FY 2026
$38.22B
Explain this page
Arphra AIPlain-English read on GlaxoSmithKline Pharmaceuticals Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,360.84
— vs spot
Recommendation
n/a
3 of 3 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Real Estate+1.94%
- Consumer Cyclical+1.72%
- Consumer Defensive+1.71%
- Communication Services+0.33%
- Financial Services+0.21%
- Industrials+0.19%
- Basic Materials+0.08%
- Healthcare-0.22%
- Utilities-0.29%
- Energy-1.13%
- Technology-1.58%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General-0.32%
- Furnishings, Fixtures & Appliances+3.58%
- Biotechnology+2.03%
- Packaged Foods+1.80%
- Broadcasting+1.60%
- Software - Infrastructure+1.55%
- Real Estate - Development-1.49%
- Medical - Equipment & Services+1.43%
- Electrical Equipment & Parts+1.11%
- Gambling, Resorts & Casinos+1.10%
- Oil & Gas Drilling+1.04%
- Internet Content & Information+0.98%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for GLAXO.BO.
Peers
No peer list available for GLAXO.BO.
Total assets
$43.24B
Total debt
$332.7M
Cash & equiv
$13.91B
Operating CF
$10.22B
Free cash flow
$9.67B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $38.22B | $12.43B | $10.36B | $61.15 | +27.11% |